Skip to content

LDA client 52551

CAPTURA BIOPHARMA

Open official API record

Source-supplied identity

Client details

Exact LDA ID: 52551
State: AR
Country: US
Source client ID: 52551

Captura is developing an orally administered MCM for radionuclide contamination.

Exact source ID relationship

Recent filings

8 total

CAPTURA BIOPHARMAHORIZONS GLOBAL SOLUTIONS LLC · 2nd Quarter (Apr 1 - June 30) 2026
Jul 13, 2026
CAPTURA BIOPHARMAHORIZONS GLOBAL SOLUTIONS LLC · 1st Quarter (Jan 1 - Mar 31) 2026
Apr 8, 2026
CAPTURA BIOPHARMAHORIZONS GLOBAL SOLUTIONS LLC · 4th Quarter (Oct 1 - Dec 31) 2025
Feb 11, 2026
CAPTURA BIOPHARMAHORIZONS GLOBAL SOLUTIONS LLC · 4th Quarter (Oct 1 - Dec 31) 2025
Feb 10, 2026
CAPTURA BIOPHARMAHORIZONS GLOBAL SOLUTIONS LLC · 4th Quarter (Oct 1 - Dec 31) 2025
Jan 8, 2026
CAPTURA BIOPHARMAHORIZONS GLOBAL SOLUTIONS LLC · 3rd Quarter (July 1 - Sep 30) 2025
Oct 8, 2025
CAPTURA BIOPHARMAHORIZONS GLOBAL SOLUTIONS LLC · 2nd Quarter (Apr 1 - June 30) 2025
Jul 8, 2025
CAPTURA BIOPHARMAHORIZONS GLOBAL SOLUTIONS LLC · 1st Quarter (Jan 1 - Mar 31) 2025
Apr 16, 2025

Identity boundary

This page groups filings only by the exact numeric identifier supplied by the LDA API. Politically.com does not merge similar names or infer organizational relationships.